Sunday, January 11, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analysts Bullish on Veeva Systems Increase Price Target to 264

Elaine Mendonca by Elaine Mendonca
March 2, 2024
in Breaking News
0
COST stock news
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter

Citigroup analyst Tyler Radke is bullish on Veeva Systems (NYSE: VEEV), maintaining a Buy rating and increasing the price target to $264, up from $240. This 10% boost in the price target shows Radke’s ongoing confidence in the company’s performance.

With a proven track record covering stocks, Radke has an impressive average return of 14.47%. Barclays and Piper Sandler analysts have also shared positive views on Veeva Systems, adding to the overall optimistic outlook for the company in the market.

As of March 2, 2024, Veeva Systems continues to garner support from analysts, signaling potential growth ahead.

Veeva Systems Inc. (VEEV) Stock Price Dips Slightly on March 2, 2024, But Remains Strong Near 52-Week Highs

On March 2, 2024, Veeva Systems Inc. (VEEV) experienced a slight decrease in its stock price, closing at $222.01. This marks a $3.50 drop from the previous market close, representing a 1.55% decrease in value. Additionally, the stock continued to decline after hours, with a further drop of $0.72.

Despite this recent decline, VEEV is still trading near the top of its 52-week range and above its 200-day simple moving average. This indicates that the stock has been performing well overall in the longer term, even with the recent dip in price.

Veeva Systems Inc. Reports Steady Financial Growth in 2024

On March 2, 2024, Veeva Systems Inc. (VEEV) reported its financial performance for the past year and the fourth quarter. The company’s total revenue for the year was $2.36 billion, which represents a 9.68% increase compared to the previous year. In the fourth quarter alone, Veeva generated $630.62 million in total revenue, which remained flat compared to the previous quarter.

Net income for the year was reported at $525.71 million, showing a 7.79% increase from the previous year. In the fourth quarter, Veeva’s net income was $147.40 million, reflecting a 9.06% increase from the previous quarter.

Earnings per share (EPS) for the year stood at $3.22, which is a 7.25% increase from the previous year. In the fourth quarter, the EPS was reported at $0.90, remaining flat compared to the previous quarter.

Overall, Veeva Systems Inc. has shown steady growth in its financial performance over the past year, with increases in total revenue, net income, and EPS. Despite the flat performance in the fourth quarter compared to the previous quarter, the company’s overall financial health remains strong.

Tags: VEEV
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Pactiv Evergreen Q4 Financial Results Revenue Decline but Positive Outlook with Restructuring Plan

The Rise of Strategic Partnerships in Life Sciences: Trends Shaping the Future of Healthcare Innovation

Rambus Stock Price Surges with Accelerated Share Repurchase Program

Finance_Capitalistic

Title Wolfe Research Analyst Initiates Coverage of Corteva with Outperform Rating and 67 Price Target

Recommended

Viking Therapeutics Stock

Viking Therapeutics: M&A Speculation Intensifies Amid Clinical Momentum

1 month ago
IsoRay Stock

Perspective Therapeutics Charts New Course with CFO Appointment Amid Technical Concerns

4 months ago
NAC Kazatomprom Stock

Uranium Sector Faces Uncertainty as Production Plans Shift

5 months ago
Centrus Energy Stock

Centrus Energy Emerges as Key Beneficiary of Nuclear Sector Revival

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Netflix Shares Under Pressure Amid High-Stakes Acquisition Battle

Marvell Technology Shares Face Conflicting Market Cues

DroneShield Shares Surge Amidst Global Defense Spending Boom

Pfizer’s Strategic Pivot Gains Momentum with Clinical and Deal Success

BYD Surpasses Tesla to Claim Global EV Sales Crown

A Trio of Catalysts Propels SpaceX Forward

Trending

Vital Farms Stock
Analysis

Vital Farms Shares Face Headwinds Amid Forecast Revisions and Insider Activity

by Andreas Sommer
January 11, 2026
0

Shares of the ethical food company Vital Farms, known for its pasture-raised eggs and dairy products, remain...

Palantir Stock

Palantir Shares: A Wall Street Divide and a Bold New Price Target

January 11, 2026
Nvidia Stock

Nvidia Accelerates AI Dominance with Early Chip Launch and Strategic Expansions

January 11, 2026
Netflix Stock

Netflix Shares Under Pressure Amid High-Stakes Acquisition Battle

January 11, 2026
Marvell Technology Stock

Marvell Technology Shares Face Conflicting Market Cues

January 11, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Vital Farms Shares Face Headwinds Amid Forecast Revisions and Insider Activity
  • Palantir Shares: A Wall Street Divide and a Bold New Price Target
  • Nvidia Accelerates AI Dominance with Early Chip Launch and Strategic Expansions

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com